Structural insights into human GPCR protein OA1: a computational perspective
暂无分享,去创建一个
Uddhavesh Sonavane | Anirban Ghosh | R. Joshi | U. Sonavane | G. K. Aradhyam | Anirban Ghosh | Rajendra Joshi | Sai Krishna Andhirka | Gopala Krishna Aradhyam
[1] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[2] K. Hideg,et al. Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. , 1993, Science.
[3] A. Ballabio,et al. Ocular albinism: evidence for a defect in an intracellular signal transduction system , 1999, Nature Genetics.
[4] Rolf Apweiler,et al. The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998 , 1998, Nucleic Acids Res..
[5] Jae Yoon Chung,et al. Correlation between Performance of QM/MM Docking and Simple Classification of Binding Sites , 2009, J. Chem. Inf. Model..
[6] C. Tacchetti,et al. The ocular albinism type 1 (OA1) protein and the evidence for an intracellular signal transduction system involved in melanosome biogenesis. , 2005, Pigment cell research.
[7] Siavoush Dastmalchi,et al. Modelling the structures of G protein-coupled receptors aided by three-dimensional validation , 2007, BMC Bioinformatics.
[8] E. Novellino,et al. Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists. , 2005, Journal of medicinal chemistry.
[9] Berk Hess,et al. P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. , 2008, Journal of chemical theory and computation.
[10] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[11] Judith Klein-Seetharaman,et al. Dynamics in Rhodopsin , 2002, Chembiochem : a European journal of chemical biology.
[12] M. Parrinello,et al. Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.
[13] D. Eisenberg,et al. VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.
[14] Ron O Dror,et al. Identification of two distinct inactive conformations of the β2-adrenergic receptor reconciles structural and biochemical observations , 2009, Proceedings of the National Academy of Sciences.
[15] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[16] J. Ballesteros,et al. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.
[17] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[18] David S. Cafiso,et al. Identifying conformational changes with site-directed spin labeling , 2000, Nature Structural Biology.
[19] M. Lohse,et al. Measurement of the millisecond activation switch of G protein–coupled receptors in living cells , 2003, Nature Biotechnology.
[20] Thomas Huber,et al. Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors. , 2008, Journal of molecular biology.
[21] Marta Filizola,et al. Modeling activated states of GPCRs: the rhodopsin template , 2006, J. Comput. Aided Mol. Des..
[22] A. Ballabio,et al. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome , 1995, Nature Genetics.
[23] Hao Fan,et al. Refinement of homology‐based protein structures by molecular dynamics simulation techniques , 2004, Protein science : a publication of the Protein Society.
[24] S. Karnik,et al. Ligand-specific Conformation of Extracellular Loop-2 in the Angiotensin II Type 1 Receptor* , 2010, The Journal of Biological Chemistry.
[25] H. Khorana,et al. Structural features of the C-terminal domain of bovine rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.
[26] Nagarajan Vaidehi,et al. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. , 2008, Journal of molecular biology.
[27] J. Ballesteros,et al. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.
[28] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[29] Tod D Romo,et al. Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics. , 2010, Biophysical journal.
[30] Rolf Apweiler,et al. The SWISS-PROT protein sequence data bank and its supplement TrEMBL , 1997, Nucleic Acids Res..
[31] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[32] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[33] R. Sowdhamini,et al. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding. , 2009, Molecular bioSystems.
[34] A. Ballabio,et al. The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells , 2008, Human molecular genetics.
[35] Francesca Fanelli,et al. Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling , 2006, J. Comput. Aided Mol. Des..
[36] Thomas B Woolf,et al. Molecular dynamics simulation of dark-adapted rhodopsin in an explicit membrane bilayer: coupling between local retinal and larger scale conformational change. , 2003, Journal of molecular biology.
[37] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[38] Stefano Costanzi,et al. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. , 2008, Journal of medicinal chemistry.
[39] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[40] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[41] Robert D. Finn,et al. The Pfam protein families database , 2004, Nucleic Acids Res..
[42] S. A. Hassan,et al. Key issues in the computational simulation of GPCR function: representation of loop domains , 2002, J. Comput. Aided Mol. Des..
[43] L. Holm,et al. The Pfam protein families database , 2005, Nucleic Acids Res..
[44] D. Farrens,et al. Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.
[45] Manfred Burghammer,et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.
[46] C. Decatur,et al. L-DOPA Is an Endogenous Ligand for OA1 , 2008, PLoS biology.
[47] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[48] Burkhard Rost,et al. The PredictProtein server , 2003, Nucleic Acids Res..
[49] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.
[50] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[51] Mark S. P. Sansom,et al. Molecular dynamics simulations and membrane protein structure quality , 2008, European Biophysics Journal.
[52] Christian Kandt,et al. Setting up and running molecular dynamics simulations of membrane proteins. , 2007, Methods.
[53] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[54] R. Wolf,et al. Homology Modeling of the Transmembrane Domain of the Human Calcium Sensing Receptor and Localization of an Allosteric Binding Site* , 2004, Journal of Biological Chemistry.
[55] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[56] Kenneth Lundstrom,et al. An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRs , 2009, Methods in molecular biology.
[57] B. Kobilka. G protein coupled receptor structure and activation. , 2007, Biochimica et biophysica acta.
[58] K. Kidd,et al. OA1 mutations and deletions in X-linked ocular albinism. , 1998, American journal of human genetics.
[59] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[60] F. de Nigris,et al. Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. , 1995, Human molecular genetics.
[61] W. Hubbell,et al. Sequence of late molecular events in the activation of rhodopsin , 2007, Proceedings of the National Academy of Sciences.
[62] Cheng Zhang,et al. Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.
[63] A. Garcia,et al. The membrane complex between transducin and dark-state rhodopsin exhibits large-amplitude interface dynamics on the sub-microsecond timescale: insights from all-atom MD simulations. , 2010, Journal of molecular biology.
[64] T. Gudermann,et al. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. , 2002, Reviews of physiology, biochemistry and pharmacology.
[65] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[66] D Bergsma,et al. Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry. , 2000, Drug design and discovery.
[67] Nagarajan Vaidehi,et al. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.
[68] S. Orlow,et al. Ocular albinism type 1: more than meets the eye. , 2001, Pigment cell research.
[69] T. A. Hall,et al. BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .
[70] J. Simms,et al. Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified. , 2007, The Journal of biological chemistry.
[71] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[72] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[73] A. Ballabio,et al. Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1. , 2000, Human molecular genetics.
[74] J M Thornton,et al. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.
[75] Prashant V Desai,et al. Homology modeling of G-protein-coupled receptors and implications in drug design. , 2006, Current medicinal chemistry.
[76] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[77] B. Kobilka,et al. New G-protein-coupled receptor crystal structures: insights and limitations. , 2008, Trends in pharmacological sciences.
[78] A. Ballabio,et al. Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. , 2000, Human molecular genetics.
[79] A. Krogh,et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.
[80] R. Piccirillo,et al. The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. , 2006, Pigment cell research.
[81] B. Kobilka. Agonist-induced conformational changes in the beta2 adrenergic receptor. , 2002, The journal of peptide research : official journal of the American Peptide Society.